Multidimensional Evaluation Of Daily Living Activities And Quality Of Life In Lung Cancer Patients

Hacettepe University

Status: Completed

Conditions: Lung Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT03881046

GO 18/737-08

Details and patient eligibility

About

The aim of our study was to compare the daily living activities with a performance-based protocol in lung cancer patients and healthy controls.

Full description

Lung cancer is the abnormal proliferation of cells in the lung tissue and a mass in the lung. The primary symptoms of this health problem include cough, dyspnea, chest pain, hemoptysis and sputum. In addition to these symptoms, muscle strength, respiratory function and effort level are decreased.

Inadequate daily living activities in cancer patients are expressed.But studies evaluating the activities of daily living in patients with lung cancer are inadequate and patients are evaluated only using scales. For the measurement of functional status in daily living activities, these scales provide important information about the detection of symptoms and the progression of the disease. However, it is very difficult to determine the limitation of perceived difficulty in daily living activities with these scales. In addition, since these scales are a method of measurement, the objectivity is open to discussion. It is thought that a performance-based protocol will facilitate the detection of limitations and provide more objective findings. We think that the Londrina protocol fully reflects the activities of daily living and thus will give us an objective measurement.

This study will show us the problem and its cause in daily life activities in patients with lung cancer.

Enrollment: 44 patients

Sex: All

Ages: 30 to 80 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• To have a diagnosis of lung cancer
• Complete chemotherapy
• Complete radiotherapy
• Coopere,
• Accepts participation in the study will be included in the study

Exclusion criteria

• Neurological, cognitive or orthopedic diseases that affect the measurements
• Acute infection
• Individuals with other chronic diseases that may affect their walking will not be included in the study

Trial design

44 participants in 2 patient groups

lung cancer

healthy control group